A Phase I Trial of Gemcitabine Followed by a Short Infusion of Flavopiridol in Patients With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2013
At a glance
- Drugs Alvocidib (Primary) ; Gemcitabine (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Biomarker
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jan 2013 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov
- 02 Jan 2013 Planned number of patients changed from 80 to 58 as reported by ClinicalTrials.gov.